Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,752,150
-$1,711,582 QoQ
Shares Held
280,405
-7.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#517
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WASHINGTON TRUST Co holds $72,307,049 across 8 Drug Manufacturers - General names. PFE ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
101,711 | $25,831,541 | |
| 2 | LLY |
ELI LILLY & Co
|
19,668 | $23,590,390 | |
| 3 | ABBV |
AbbVie Inc.
|
28,765 | $7,238,424 | |
| 4 | PFE |
Pfizer Inc
This page
|
280,405 | $6,752,150 | |
| 5 | MRK |
Merck & Co., Inc.
|
33,197 | $4,265,814 | |
| 6 | AMGN |
Amgen Inc
|
8,486 | $3,072,949 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
14,851 | $855,714 | |
| 8 | NVS |
Novartis AG
|
4,467 | $700,067 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,752,150 | 280,405 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $8,463,732 | 301,415 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $7,648,880 | 307,184 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $8,127,967 | 318,994 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,735,735 | 319,131 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,041,192 | 317,332 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $8,555,314 | 322,477 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $9,548,636 | 329,946 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $9,356,819 | 334,411 | Shares | Defined | 2024-07-15 | |
| 2024-03-31 | $9,536,092 | 343,643 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $9,979,735 | 346,639 | Shares | Defined | 2024-01-18 | |
| 2023-09-30 | $11,600,841 | 349,739 | Shares | Defined | 2023-10-18 | |
| 2023-06-30 | $12,740,246 | 347,335 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $13,877,588 | 340,137 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $17,437,278 | 340,306 | Shares | Defined | 2023-07-27 | |
| 2022-09-30 | $15,348,688 | 350,747 | Shares | Defined | 2022-10-14 | |
| 2022-06-30 | $18,526,978 | 353,366 | Shares | Defined | 2022-07-25 | |
| 2022-03-31 | $18,104,952 | 349,719 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $20,804,318 | 352,317 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $16,976,260 | 394,705 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $15,186,677 | 387,811 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $13,644,580 | 376,610 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $13,363,979 | 363,053 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $13,033,770 | 355,144 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $11,100,090 | 339,452 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $11,893,476 | 364,384 | Shares | Defined | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||